Treatment of periodontitis ameliorates the severity and extent of psoriasis—A randomized clinical trial
Journal of Periodontal Research · 2025
DOI: 10.1111/jre.13314 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontal Research, 2025. Verfasst von Crystal Marruganti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Periodontology, Endodontology and Restorative Dentistry, Department of Medical Biotechnologies, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Psoriasis, Periodontitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Aim
To assess the impact of non‐surgical periodontitis treatment over conventional dermatological treatment on the severity and extent of psoriasis in patients affected by comorbid psoriasis and periodontitis.
Methods
Seventy‐four patients affected by both psoriasis and Stages I–IV periodontitis were randomized to receive either Steps 1–2 (non‐surgical) of periodontal therapy (test group; n = 37) or no treatment (control group; n = 37). The two groups were balanced in terms of psoriasis medications, with the majority of the included patients undergoing biologics (74.0%) as monotherapy, while minor proportions were under systemic medications (13.7%) or none/topical/phototherapy (12.3%). The psoriasis area severity index (PASI) was regarded as the primary outcome. The Body Surface Area (BSA) and the Dermatology Life Quality Index (DLQI) were additionally considered as dermatological outcomes. Probing pocket depth, recession depth, clinical attachment level, periodontal inflamed surface area, and full‐mouth plaque and bleeding scores were also measured. [Correction added on July 5, 2024, after first online publication: The preceding sentence has been revised].
Results
Periodontal therapy in the test group led to statistically significant lower PASI scores at 10 weeks (mean = 3.15; standard deviation [SD] = 3.78) compared to the control group (mean = 7.11; SD = 6.09) (mean difference [MD] = ‐4.0; 95% confidence interval [CI]: −6.3, −1.6; p = .001). The test group also showed improvements in BSA (MD = −4.3) and periodontal parameters compared to the control group. DLQI only showed a non‐statistically significant tendency (MD = −2.0).
Conclusion
Steps 1–2 of periodontal therapy showed an additional effect over conventional dermatological treatment in reducing the severity and extent of psoriasis ( Clinicaltrials.gov : NCT05311501).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Periodontology, Endodontology and Restorative Dentistry, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
- Unit of Periodontology, UCL Eastman Dental Institute, London, UK.
- Department of Periodontology, Faculty of Dentistry, University of Oslo, Oslo, Norway.
- Unit of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy.
ORCID-Profile: Crystal Marruganti, Mario Romandini
Zitieren
APA
Marruganti, C., Romandini, M., Gaeta, C., Trovato, E., Cinotti, E., Rubegni, P., D'Aiuto, F., & Grandini, S. (2025). Treatment of periodontitis ameliorates the severity and extent of psoriasis—A randomized clinical trial. Journal of Periodontal Research. https://doi.org/10.1111/jre.13314
Vancouver
Marruganti C, Romandini M, Gaeta C, Trovato E, Cinotti E, Rubegni P, et al. Treatment of periodontitis ameliorates the severity and extent of psoriasis—A randomized clinical trial. Journal of Periodontal Research. 2025. doi:10.1111/jre.13314
BibTeX
@article{Marruganti2025,
author = {Marruganti, Crystal and Romandini, Mario and Gaeta, Carlo and Trovato, Emanuele and Cinotti, Elisa and Rubegni, Pietro and D'Aiuto, Francesco and Grandini, Simone},
title = {Treatment of periodontitis ameliorates the severity and extent of psoriasis—A randomized clinical trial},
journal = {Journal of Periodontal Research},
year = {2025},
doi = {10.1111/jre.13314}
}
EUVIMED